Evolve
Payments companies reported to CMS as associated with Evolve. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Evolve, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Evolve
These are the largest totals companies reported as associated with Evolve. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Alexander Aleem | Saint Louis, MO | Orthopaedic Surgery | $15,750.00 |
| Mark Bain | Cleveland, OH | Neurological Surgery | $14,570.52 |
| Mario Zanaty | Iowa City, IA | Neurological Surgery | $9,094.85 |
| Ansaar Rai | Morgantown, WV | Neuroradiology | $8,259.27 |
| Justin Singer | Grand Rapids, MI | Neurological Surgery | $6,374.13 |
| Ajay Wakhloo | Worcester, MA | Diagnostic Radiology | $5,975.51 |
| Alexander Coon | Baltimore, MD | Neurological Surgery | $5,396.78 |
| Vasu Saini | Miami Beach, FL | Vascular & Interventional Radiology | $4,532.92 |
| Ben Waldau | Sacramento, CA | Neurological Surgery | $4,176.67 |
| Brian Jankowitz | Philadelphia, PA | Neurological Surgery | $3,874.33 |
Prescribed Evolve?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.